DK1032374T3 - Sphroider, fremgangsmåde og farmaceutiske præparater - Google Patents

Sphroider, fremgangsmåde og farmaceutiske præparater

Info

Publication number
DK1032374T3
DK1032374T3 DK98954683T DK98954683T DK1032374T3 DK 1032374 T3 DK1032374 T3 DK 1032374T3 DK 98954683 T DK98954683 T DK 98954683T DK 98954683 T DK98954683 T DK 98954683T DK 1032374 T3 DK1032374 T3 DK 1032374T3
Authority
DK
Denmark
Prior art keywords
spheroids
pharmaceutical preparations
sphroids
methods
tiagabine
Prior art date
Application number
DK98954683T
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Application granted granted Critical
Publication of DK1032374T3 publication Critical patent/DK1032374T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK98954683T 1997-11-21 1998-11-19 Sphroider, fremgangsmåde og farmaceutiske præparater DK1032374T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714631A FR2771291B1 (fr) 1997-11-21 1997-11-21 Spheroides, procede de preparation et compositions pharmaceutiques
PCT/IB1998/001911 WO1999026608A1 (fr) 1997-11-21 1998-11-19 Spheroides, procede de preparation et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
DK1032374T3 true DK1032374T3 (da) 2003-11-24

Family

ID=9513635

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98954683T DK1032374T3 (da) 1997-11-21 1998-11-19 Sphroider, fremgangsmåde og farmaceutiske præparater

Country Status (29)

Country Link
US (1) US6077544A (da)
EP (1) EP1032374B1 (da)
JP (1) JP2001523706A (da)
KR (1) KR100502938B1 (da)
CN (1) CN1223341C (da)
AT (1) ATE246496T1 (da)
AU (1) AU744580B2 (da)
BG (1) BG65117B1 (da)
BR (1) BR9814672A (da)
CA (1) CA2310147C (da)
CZ (1) CZ299110B6 (da)
DE (1) DE69817010T2 (da)
DK (1) DK1032374T3 (da)
EA (1) EA003324B1 (da)
ES (1) ES2203989T3 (da)
FR (1) FR2771291B1 (da)
HR (1) HRP20000323B1 (da)
HU (1) HU230053B1 (da)
IL (2) IL136215A0 (da)
MX (1) MXPA00004959A (da)
NO (1) NO329728B1 (da)
NZ (1) NZ504662A (da)
PL (1) PL193878B1 (da)
PT (1) PT1032374E (da)
SK (1) SK284493B6 (da)
TR (1) TR200002130T2 (da)
WO (1) WO1999026608A1 (da)
YU (1) YU31000A (da)
ZA (1) ZA9810631B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
EP1414956B1 (en) 2001-06-22 2007-10-24 Genencor International, Inc. Highly impact-resistant granules
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
WO2003084517A2 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
NZ523946A (en) * 2003-01-31 2004-06-25 Carl Ernest Alexander Portable hygiene compositions comprising a semi-solid gel and active ingredients in bead form for use in personal oral, dental or skin care
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
KR101148734B1 (ko) * 2003-10-10 2012-07-05 에띠빠흠 징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
FR2861990B1 (fr) 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
EP1737433B1 (en) * 2004-04-12 2007-11-14 Pfizer Products Incorporated Taste-masked drugs in rupturing multiparticulates
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20070286900A1 (en) 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US10357462B2 (en) * 2006-11-30 2019-07-23 Ben Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
EP2468263A1 (en) 2010-12-23 2012-06-27 Laboratorios Del. Dr. Esteve, S.A. Compressed solid dosage forms
WO2019217645A1 (en) 2018-05-11 2019-11-14 Stolle Machinery Company, Llc Process shaft tooling assembly
JP7167186B2 (ja) 2018-05-11 2022-11-08 ストール マシーナリ カンパニー，エルエルシー クイック交換移送アセンブリ
US11565303B2 (en) 2018-05-11 2023-01-31 Stolle Machinery Company, Llc Rotary manifold
CN112118920B (zh) 2018-05-11 2023-04-14 斯多里机械有限责任公司 驱动组件
BR112020022997A2 (pt) 2018-05-11 2021-02-02 Stolle Machinery Company, Llc conjunto de ferramentas de mudança rápida
EP3791168A4 (en) 2018-05-11 2021-08-18 Stolle Machinery Company, LLC ARRANGEMENT FOR A COMPLETE INSPECTION OF THE FEEDER ASSEMBLY
BR112020022970A2 (pt) 2018-05-11 2021-02-02 Stolle Machinery Company, Llc recursos de mudança rápida de conjunto de alimentação
US11420242B2 (en) 2019-08-16 2022-08-23 Stolle Machinery Company, Llc Reformer assembly

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
NZ230763A (en) * 1988-09-27 1991-10-25 Takeda Chemical Industries Ltd Production of granules having a core by spraying the cores with a dispersion of hydroxypropylcellulose, optionally incorporating an active ingredient
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
NZ268003A (en) * 1993-06-14 1996-11-26 Janssen Pharmaceutica Nv Extended release coated tablets comprising pseudoephedrine in a coated core, the coating comprising pseudoephedrine and astemizole intermediate an inner extended release coating and an outer seal coating
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
JP2001523706A (ja) 2001-11-27
HRP20000323B1 (en) 2006-07-31
HU230053B1 (hu) 2015-06-29
EA200000548A1 (ru) 2000-12-25
KR20010032329A (ko) 2001-04-16
BG65117B1 (bg) 2007-03-30
EA003324B1 (ru) 2003-04-24
US6077544A (en) 2000-06-20
PL340659A1 (en) 2001-02-12
CA2310147C (fr) 2010-05-25
SK7562000A3 (en) 2001-06-11
ZA9810631B (en) 1999-05-24
NO329728B1 (no) 2010-12-06
IL136215A0 (en) 2001-05-20
ATE246496T1 (de) 2003-08-15
SK284493B6 (sk) 2005-05-05
HUP0100562A2 (hu) 2002-05-29
AU1170499A (en) 1999-06-15
NO20002605D0 (no) 2000-05-19
PL193878B1 (pl) 2007-03-30
WO1999026608A1 (fr) 1999-06-03
EP1032374A1 (fr) 2000-09-06
BG104511A (en) 2001-04-30
NO20002605L (no) 2000-07-05
HUP0100562A3 (en) 2002-08-28
ES2203989T3 (es) 2004-04-16
NZ504662A (en) 2002-09-27
IL136215A (en) 2006-12-31
AU744580B2 (en) 2002-02-28
YU31000A (sh) 2002-11-15
FR2771291A1 (fr) 1999-05-28
CN1282239A (zh) 2001-01-31
CZ20001849A3 (cs) 2000-10-11
EP1032374B1 (fr) 2003-08-06
FR2771291B1 (fr) 2000-02-25
CZ299110B6 (cs) 2008-04-23
DE69817010D1 (de) 2003-09-11
BR9814672A (pt) 2000-10-03
CA2310147A1 (fr) 1999-06-03
HRP20000323A2 (en) 2001-06-30
MXPA00004959A (es) 2002-10-17
KR100502938B1 (ko) 2005-07-25
CN1223341C (zh) 2005-10-19
TR200002130T2 (tr) 2000-12-21
PT1032374E (pt) 2003-12-31
DE69817010T2 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
DK1032374T3 (da) Sphroider, fremgangsmåde og farmaceutiske præparater
DK1032391T3 (da) Sfæroider indeholdende tiagabin, fremstillingsproces og farmaceutisk sammensætning
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
SE9704545D0 (sv) Novel compounds
MY112123A (en) Process for preparing tablets containing paroxetine
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
EP0932613A4 (en) EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
NO883047D0 (no) Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytise tilberedninger inneholdende dem og deres anvendelse.
NO20014803D0 (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
DK191290A (da) Extracellulaer exopolymer, fremgangsmaade til fremstilling af samme og farmaceutiske praeparater indeholdende exopolymeren
SE9803277D0 (sv) Novel compounds
UA37104A (uk) Спосіб лікування гепатоцеребральної дистрофії (хвороби вільсона-коновалова)